Business Services
Pharmaceutical Business Services – News, analysis and company profiles
OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology
February 22, 2023 Business Services
Nantes, France – February 22, 2023, 6:00 p.m.
PHARMANOVIA ENTERS IN-LICENSING AGREEMENT WITH AXSOME THERAPEUTICS TO MARKET AND FURTHER DEVELOP SUNOSI® (SOLRIAMFETOL), A FIRST-IN-CLASS TREATMENT FOR EXCESSIVE DAYTIME SLEEPINESS (EDS) IN PEOPLE WITH NARCOLEPSY AND OBSTRUCTIVE SLEEP APNOEA
February 22, 2023 Business Services
BASILDON, UK, 22 February 2023 Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the lifecycle of already …
Relation Therapeutics announces launch of flagship integrated wet–dry laboratory at the heart of London’s Knowledge Quarter
February 22, 2023 Business Services
London, February 22, 2023 – Relation Therapeutics, a leader in the use of high-resolution biology, machine learning and clinical insights …
NICE Publishes Reimbursement Recommendation for Translarna™
February 22, 2023 Business Services
London, UK, 22nd February, 2023 — PTC Therapeutics, Ltd. today announced the National Institute for Health and Care Excellence (NICE) has published …
Indegene launches Metaverse capabilities to help life sciences companies create immersive healthcare experiences
February 22, 2023 Business Services
Princeton, United States / Bengaluru, India, February 21, 2023: Indegene, a digital-first, life sciences commercialization company today announced the launch …
Modus Therapeutics announces positive topline data from its Phase 1b LPS provocation study evaluating the potential of sevuparin for treatment of sepsis
February 22, 2023 Business Services
STOCKHOLM, SWEDEN – 21 February 2023: Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet …
Beckley Psytech receives FDA Investigational New Drug (IND) approval for Phase IIb study of BPL-003, a novel synthetic formulation of 5-MeO-DMT (Mebufotenin)
February 21, 2023 Business Services
Oxford, United Kingdom – 21 FEBRUARY 2023 – Beckley Psytech Ltd, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric …
AstraZeneca and MSD present final results of key secondary overall survival endpoint from Phase III PROpel trial at ASCO GU Cancers Symposium
February 20, 2023 Business Services
Results from the final prespecified overall survival (OS) analysis of the PROpel Phase III trial in metastatic castration-resistant prostate cancer …
SMC recommends Opdivo® (nivolumab) for use post-surgery in specific urothelial cancer patients
February 20, 2023 Business Services
(Uxbridge, Middlesex, 13 February 2023) – The Scottish Medicines Consortium (SMC) has accepted Bristol Myers Squibb’s (BMS’) nivolumab for the …
Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma
February 20, 2023 Business Services
PARIS, FRANCE, STRICTLY EMBARGOED until 11.00pm CET, 13 February 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced three-year minimum, …
Janssen Presents Updated Data Demonstrating Improved Outcomes from the Use of Niraparib in Combination with Abiraterone Acetate Plus Prednisone as a First-Line Therapy in Patients with BRCA-Positive Metastatic CastrationResistant Prostate Cance
February 20, 2023 Business Services
BEERSE, BELGIUM, 16 February 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated results from the …
UK pharma packaging giant Origin celebrates its 60th anniversary
February 13, 2023 Business Services
13th FEBRUARY 2023, HULL, UK: Leading UK pharmaceutical packaging and solutions provider, Origin, is celebrating its 60th anniversary. Origin …
CYDAR MEDICAL RAISES $11.5M (£9.3M) IN SERIES A FUNDING ROUND
February 13, 2023 Business Services
CAMBRIDGE, UNITED KINGDOM, 13 FEBRUARY 2023 – Cydar Medical (“Cydar” or “the Company”) a global, cloud-based surgical software company, announces …
RQ Bio Strengthens Board with Industry-leading Infectious Disease Experts Joining as Non-Executive Directors
February 9, 2023 Business Services
LONDON, UK, 9 February 2023 — RQ Bio is scaling up at speed, with the appointment of Non-Executive Directors, Dr …
Latest content
Pharma sees climate disruption as growing supply-chain risk
September 11, 2026
Manchester NHS-MHRA partnership to test new technologies in real-world care
September 10, 2026
